Cytogenetic and molecular genetic evolution of chronic myeloid leukemia

Acta Haematologica

Volumn 107, Issue 2, 2002, Pages 76-94

  Johansson, Bertil ^a   Fioretos, Thoas ^a   Mitelman, Felix ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Chromosomes; Chronic myeloid leukemia; Genes; Progression

Indexed keywords

ALPHA INTERFERON; BCR ABL PROTEIN; BUSULFAN; HYDROXYUREA; TELOMERASE;

BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CHROMOSOME 11Q; CHROMOSOME 12Q; CHROMOSOME 17Q; CHROMOSOME 19Q; CHROMOSOME 1Q; CHROMOSOME 21Q; CHROMOSOME 22Q; CHROMOSOME 3Q; CHROMOSOME 5Q; CHROMOSOME 6Q; CHROMOSOME 9Q; CHROMOSOME ABERRATION; CHROMOSOME BANDING PATTERN; CHROMOSOME BREAKAGE; CHROMOSOME INVERSION; CHROMOSOME REARRANGEMENT; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; ENZYME ACTIVITY; GENE DELETION; GENE FUSION; GENE MUTATION; GENETIC VARIABILITY; HUMAN; LYMPHOID CELL; MOLECULAR GENETICS; MONOSOMY 7; PRIORITY JOURNAL; PROGNOSIS; RECIPROCAL CHROMOSOME TRANSLOCATION; REVIEW; TUMOR SUPPRESSOR GENE;

CYTOGENETIC ANALYSIS; DISEASE PROGRESSION; EVOLUTION, MOLECULAR; GENE REARRANGEMENT; HUMANS; LEUKEMIA, MYELOID, CHRONIC; PHILADELPHIA CHROMOSOME; TRANSLOCATION, GENETIC;

EID: 0036202470     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000046636     Document Type: Review

References (206)

1. A minute chromosome in human chronic granulocytic leukemia
2. Chromosome studies on normal and leukemic human leukocytes
3. Identification of the Philadelphia chromosome as a number 22 by quinacrine mustard fluorescence analysis
4. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining
5. 1-positive chronic granulocytic leukaemia
6. 1 translocation
7. Fused transcript of abl and bcr genes in chronic myelogenous leukaemia
8. Chronic myelogenous leukaemia - New therapeutic principles
9. A possible specific chromosome abnormality in human chronic myeloid leukaemia
10. Cytogenetic studies on bone-marrow in chronic myeloid leukaemia
11. The distribution of the Philadelphia chromosome in patients with chronic myelogenous leukemia
12. Comparison of Philadelphia chromosome-positive and -negative patients with chronic myelocytic leukemia
13. Chromosomal alteration of erythropoietic cells in chronic myeloid leukemia
14. Involvement of the erythroid series in blastic crisis of chronic myeloid leukaemia
15. Clonal origin of chronic myelocytic leukemia in man
16. 1 chromosome in erythroid cells
17. The Philadelphia chromosome in human macrophages
18. Clonal origin of the Philadelphia chromosome and chronic myeloid leukaemia: Evidence from a sex chromosome mosaic
19. Clonal origin of chronic myelocytic leukemia
20. Evidence for the clonal origin of chronic myeloid leukemia from a sex chromosome mosaic: Clinical, cytogenetic, and marrow culture studies
21. Chromosomes and leukemia
22. Chromosome changes in primary tumors
23. Chromosomes and leukaemia
24. Chromosome changes in the terminal stages of chronic granulocytic leukaemia
25. Some current problems of cancer cytogenetics
26. Cytogenetic evolution and clonal proliferation in acute transformation of chronic granulocytic leukaemia
27. A chromosomal theory of carcinogenesis
28. Chromosome studies in hematological disorders. I. Chromosome findings in chronic myelogenous leukemia with special reference to those after blastic transformation
29. Chromosomal abnormalities in human neoplasia
30. The karyotype evolution in chronic granulocytic leukaemia. II. The chromosome and karyotype pattern of advanced evolution
31. Chromosome changes in the blastic transformation stage of chronic granulocytic leukaemia
32. Clinical implications of cytogenetic variants in chronic myelocytic leukemia (CML)
33. The chromosomes in ontogeny and oncogeny
34. Chromosomal evolution in cell populations
35. Philadelphia chromosome by translocation
36. Philadelphia chromosome by translocation
37. 1-chromosome: Translocation to chromosome 9
38. 1 chromosome
39. A new translocation related to the Philadelphia chromosome
40. G/G translocation and chronic myelocytic leukaemia
41. Chronische myeloische Leukämie mit Philadelphia-Chromosom und Tandem-Translokation am 2. Chromosom Nr. 22; 46, XX, tan(22q+;22q-)
42. 1 negative chronic myelocytic leukemia in the chronic or blastic stage
43. 1 in chronic myeloid leukaemia
44. 1 translocations
45. 1 chromosome in chronic granulocytic leukaemia
46. Chromosome banding studies in Philadelphia chromosome positive myeloid leukaemia
47. 1 translocations and their clinical significance
48. Transposition of 9q34 and 22 (q11-qter) regions has a specific role in chronic myelocytic leukemia
49. Cytogenetic findings in chronic myeloid leukemia (CML); evaluation of karyotype, blast morphology, and survival in the acute phase
50. Cytogenetic follow-up of patients with nonlymphocytic leukemia I. Philadelphia chromosome-positive chronic myeloid leukemia
51. Correlations between the clinical course, characteristics of blast cells, and karyotype patterns in chronic myeloid leukemia
52. 1) translocations in chronic myeloid leukemia
53. Significance of non-standard Philadelphia chromosomes in chronic granulocytic leukaemia
54. 1 translocations in CML and their incidence, including two cases with sequential lymphoid and myeloid crises
55. Chromosome banding studies in 106 cases of chronic myelogenous leukemia
56. 1-positive chronic myeloid leukemia
57. Philadelphia chromosome (Ph) positive chronic myelocytic leukemia (CML): Frequency of additional findings
58. Unusual Ph translocations in the French prospective study on chronic myeloid leukemia
59. Variant Ph translocations in chronic myeloid leukemia
60. 1 and other translocations in CML
61. Variant Philadelphia translocations in chronic myeloid leukemia
62. Genomic diversity of Philadelphia-positive chronic myelogenous leukemia
63. Clinical implications of fluorescence in situ hybridization analysis in 13 chronic myeloid leukemia cases: Ph-negative and variant Ph-positive
64. 1 translocation?
65. Translocation of c-abl to 'masked' Ph in chronic myeloid leukemia
66. The Philadelphia chromosome. Considerations based on studies of variant Ph translocations
67. Cytogenetics of chronic myelogenous leukemia
68. Chromosomal in situ hybridization and Southern blot analyses using c-abl, c-sis, or bcr probe in chronic myelogenous leukemia cells with variant Philadelphia translocations
69. Complex translocations of the Ph chromosome and Ph negative CML arise from similar mechanisms, as evidenced by FISH analysis
70. Complex chromosomal translocations in the Philadelphia chromosome leukemias. Serial translocations or a concerted genomic rearrangement?
71. Molecular cloning of the breakpoints of a complex Philadelphia chromosome translocation: Identification of a repeated region on chromosome 17
72. A FISH study of variant Philadelphia rearrangements
73. Non-random karyotypic evolution in chronic myeloid leukemia
74. Non-random and random chromosomal abnormalities in transformed chronic granulocytic leukaemia
75. Myeloid karyotype and the malignant phase of chronic granulocytic leukaemia
76. Chromosome abnormalities and clinical and morphologic manifestations of chronic myeloid leukemia
77. Non-random clonal evolution in 45 cases of chronic myeloid leukemia
78. Chromosome banding patterns in patients with chronic myelocytic leukemia
79. A summary of cytogenetic studies on 534 cases of chronic myelocytic leukemia in Japan
80. Cytogenetic studies of bone marrow and extramedullary tissues and clinical course during metamorphosis of chronic myelocytic leukemia
81. Application of log-linear model in inference on karyotypic evolution in chronic myelocytic leukemia
82. Primary vs. secondary neoplasia-associated chromosomal abnormalities - Balanced rearrangements vs. genomic imbalances?
83. t(15;17) in a promyelocytic form of chronic myeloid leukemia blastic crisis
84. Clinical correlations of the 3q21;q26 cytogenetic anomaly. A leukemic or myelodysplastic syndrome with preserved or increased platelet production and lack of response to cytotoxic drug therapy
85. Association of a chromosomal 3;21 translocation with the blast phase of chronic myelogenous leukemia
86. Reciprocal translocation involving the short arms of chromosomes 7 and 11, t(7p-;11p+), associated with myeloid leukemia with maturation
87. Ph-positive chronic myeloid leukemia with t(8;21)(q22;q22) in blastic crisis
88. Acute myelomonocytic leukemia with inv(16)(p13q22) complicating Philadelphia chromosome positive chronic myeloid leukemia
89. Is cancer cytogenetics reducible to the molecular genetics of cancer cells?
90. Genomic alterations involving the c-myc proto-oncogene locus during the evolution of a case of chronic granulocytic leukaemia
91. Molecular characteristics of chronic myelogenous leukemia in blast crisis
92. Detection of c-myc oncogene amplification in a CML blastic phase patient with double minute chromosomes
93. c-myc locus amplification and the acquisition of trisomy 8 in the evolution of chronic myeloid leukemia
94. Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics
95. Translocation t(17;18)(q10;q10). A new non-random chromosomal translocation of clonal evolution in chronic myeloid leukemia
96. Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia
97. Rearrangements in the p53 gene in Philadelphia chromosome positive chronic myelogenous leukemia
98. p53 in chronic myelogenous leukemia in acute phase
99. Correlation between molecular and clinical events in the evolution of chronic myelocytic leukemia to blast crisis
100. The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia
101. Mutations of the p53 tumor suppressor gene in hematologic neoplasms
102. Genetic alterations in the p53 gene in the blast crisis of chronic myelogenous leukemia: Analysis by polymerase chain reaction based techniques
103. Molecular defects associated with the acute phase CML
104. Molecular alterations in the TP53 gene of peripheral blood cells of patients with chronic myeloid leukemia
105. 1-positive or -negative myeloid leukemia
106. Analysis of the p53 gene in myeloid malignancies associated with chromosomal abnormalities involving the short arm of chromosome 17
107. Isochromosome 17q in blast crisis of chronic myeloid leukemia and in other hematologic malignancies is the result of clustered breakpoints in 17p11 and is not associated with coding TP53 mutations
108. Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia
109. Involvement of the cyclin-dependent kinase-4 inhibitor (CDKN2) gene in the pathogenesis of lymphoid blast crisis of chronic myelogenous leukaemia
110. Expression of cell cycle regulatory genes in chronic myelogenous leukemia
111. p16INK4A and p15INK4B gene deletions in primary leukemias
112. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells
113. Absence of the human retinoblastoma gene product in the megakaryoblastic crisis of chronic myelogenous leukemia
114. Genetic analysis of p53 and RB1 tumor-suppressor genes in blast crisis of chronic myeloid leukemia
115. Hemizygous deletion of the 3′ end of the RB1 gene in a case of Philadelphia positive-acute lymphoblastic leukemia
116. Abnormalities of the retinoblastoma gene in the pathogenesis of acute leukemia
117. Alterations of p53 and RB genes and the evolution of the accelerated phase of chronic myeloid leukemia
118. Decreases in Ikaros activity correlate with blast crisis in patients with chronic myelogenous leukemia
119. Allelotype analysis in the evolution of chronic myelocytic leukemia
120. Chromosome band 1p36 contains a putative tumor suppressor gene important in the evolution of chronic myelocytic leukemia
121. Molecular genetic basis of pancreatic adenocarcinoma
122. Genomic instability of microsatellite repeats and its association with the evolution of chronic myelogenous leukemia
123. Genetic instability of a dinucleotide repeat-rich region in three hematologic malignancies
124. No evidence for microsatellite instability or consistent loss of heterozygosity at selected loci in chronic myeloid leukaemia blast crisis
125. Absence of microsatellite instability during the progression of chronic myelocytic leukemia
126. Chronic myeloid leukemia from basics to bedside
127. Ras oncogene mutations are rare late stage events in chronic myelogenous leukemia
128. Rare occurrence of N-ras point mutations in Philadelphia chromosome positive chronic myeloid leukemia
129. Mutations of the Ras protooncogenes in chronic myelogenous leukemia: A high frequency of Ras mutations in bcr/abl rearrangement-negative chronic myelogenous leukemia
130. Absence of N-ras mutations in myeloid and lymphoid blast crisis of chronic myeloid leukemia
131. High frequency of RAS oncogene mutation in chronic myeloid leukemia patients with myeloblastoma
132. Mutations of the transcription factor AML1/ CBFA2 are uncommon in blastic transformation of chronic myeloid leukemia
133. Chronic myelogenous leukemia: Amplification of a rearranged c-abl oncogene in both chronic phase and blast crisis
134. Heterogeneity in expression of the bcr-abl fusion transcript in CML blast crisis
135. Increase of BCR-ABL chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression
136. Derivative chromosomes of 11q23-translocations in hematologic malignancies
137. Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia
138. AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia
139. Expression of the EVI1 gene in chronic myelogenous leukemia in blast crisis
140. Identification of translocational breakpoints within the intron region before the last coding exon (exon 12) of the EVI1 gene in two cases of CML-BC with inv(3)(q21q26)
141. Increased Evi-i expression is frequently observed in blastic crisis of chronic myelocytic leukemia
142. Detection of fusion transcripts generated by the inversion 16 chromosome in acute myelogenous leukemia
143. Identical fusion transcript associated with different breakpoints in the AML1 gene in simple and variant t(8;21) acute myeloid leukemia
144. Expression of the NUP98/HOXA9 fusion transcript in the blast crisis of Philadelphia chromosome-positive chronic myelogenous leukaemia with t(7;11)(p15;p15)
145. Molecular characterization of 12p abnormalities in hematologic malignancies: Deletion of KIP1, rearrangement of TEL, and amplification of CCND2
146. Myeloid- and lymphoid-specific breakpoint cluster regions in chromosome band 13q14 in acute leukemia
147. Additional t(11;17)(q23;q21) in a patient with Philadelphia-positive mixed lineage antigen-expressing leukemia
148. NUP98 gene rearrangements and the clonal evolution of chronic myelogenous leukemia
149. Integration of amplified BCR/ABL fusion genes into the short arm of chromosome 17 as a novel mechanism of disease progression in chronic myeloid leukemia
150. Loss of imprinting in disease progression in chronic myelogenous leukemia
151. Abnormal methylation of the calcitonin gene marks progression of chronic myelogenous leukemia
152. Acceleration of chronic myeloid leukemia correlates with calcitonin gene hypermethylation
153. Progressive de novo DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia
154. ABL1 methylation is a distinct molecular event associated with clonal evolution of chronic myeloid leukemia
155. A novel quantitative 'stretch PCR assay', that detects a dramatic increase in telomerase activity during the progression of myeloid leukemias
156. Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression
157. Geographic heterogeneity of neoplasia-associated chromosome aberrations
158. Secondary chromosome changes in chronic myeloid leukemia: Relation to treatment
159. Karyotypic evolution in Ph-positive chronic myeloid leukemia in relation to management and disease progression
160. Karyotypic findings as an independent prognostic marker in chronic myeloid leukaemia blast crisis
161. Cytogenetic patterns following bone marrow transplantation for chronic granulocytic leukemia
162. Cytogenetics in patients with chronic myelogenous leukemia treated with bone marrow transplantation
163. Cytogenetic follow-up after bone marrow transplantation for Philadelphia-positive chronic myeloid leukemia
164. Karyotype evolution of Ph positive chronic myelogenous leukemia patients relapsed in advanced phases of the disease after allogeneic bone marrow transplantation
165. Serial cytogenetic studies in allografted patients with chronic myeloid leukemia
166. Non-random involvement of chromosome 13 in patients with persistent or relapsed disease after bone-marrow transplantation for chronic myeloid leukemia
167. Aberrant cytogenetic evolution pattern of Philadelphia-positive chronic myeloid leukemia treated with interferon-alpha
168. Significance of cytogenetic clonal evolution in chronic myelogenous leukemia
169. Emergence of new clonal abnormalities following interferon-alpha induced complete cytogenetic response in patients with chronic myeloid leukemia: Report of three cases
170. Emergence of unusual cytogenetic abnormalities under interferon-alpha therapy in patients with chronic myelogenous leukemia
171. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification
172. Chronic granulocytic leukemia: Correlation of blastic transformation type with karyotypic evolution
173. Correlation between chromosomal abnormalities and blast phenotype in the blast crisis of Ph-positive CGL
174. The karyotype of blastic crisis
175. Possible cytogenetic distinction between lymphoid and myeloid blast crisis in chronic granulocytic leukemia
176. Do chromosome abnormalities determine the type of acute leukemia that develops in CML?
177. Chromosomal characteristics of chronic and blastic phase of chronic myeloid leukemia. A study of 100 patients in India
178. Comparison of clinical and biologic features between myeloid and lymphoid transformation of Philadelphia chromosome positive chronic myeloid leukemia
179. Cytogenetic and immunogenotypic alterations of blast crisis cells in chronic myelogenous leukemia independently linked to immunophenotypic expression
180. Abnormalities of 3q21 and 3q26 in myeloid malignancy: A United Kingdom Cancer Cytogenetic Group study
181. Chromosomal, morphological and clinical correlations in blastic crisis of chronic myeloid leukaemia. A study of 69 cases
182. Correlation between acquired pseudo-Pelger-Huet anomaly and involvement of chromosome 17 in chronic myeloid leukemia
183. Blast crisis of Ph-positive chronic myeloid leukemia with isochromosome 17q: Report of 12 cases and review of the literature
184. Cytogenetic divergence of the same blastic clone in transformed chronic granulocytic leukemia: No effect on morphologic and immunologic features
185. The relationship between secondary chromosomal abnormalities and blast transformation in chronic myelogenous leukemia
186. Consistent loss of heterozygosity at 14Q32 in lymphoid blast crisis of chronic myeloid leukemia
187. Possible prediction of myeloid and lymphoid crises in chronic myelocytic leukemia at onset by determining the methylation status of the major breakpoint cluster region
188. Detection of the blastic crisis cell clone in chronic myeloid leukaemia
189. Cytogenetic studies in blast crisis of Ph-positive chronic granulocytic leukemia: Results and prognostic evaluation in 52 patients
190. Sequential karyotype study on Ph-positive chronic myelocytic leukemia. Significance of additional chromosomal abnormalities during disease evolution
191. Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients
192. Prognostic significance of cytogenetic abnormalities in patients with chronic myelogenous leukemia
193. Cytogenetic evidence for splenic origin of blastic transformation in chronic myeloid leukaemia
194. Removal of abnormal clone of leukaemic cells by splenectomy
195. Abnormal clones resembling those seen in blast crisis arising in the spleen in chronic myelocytic leukemia
196. Therapeutic and prognostic value of initial chromosomal findings at the blastic phase of Ph1-positive chronic myeloid leukemia
197. Transformation of chronic myelogenous leukemia: Clinical, morphologic, and cytogenetic features
198. Value of cytogenetic studies in prediction of acute phase CML
199. Prognostic significance of additional cytogenetic abnormalities at diagnosis of Philadelphia chromosome-positive chronic granulocytic leukemia
200. Abnormalities of chromosome No. 17 in myeloproliferative disorders
201. 1-positive chronic myeloid leukaemia (CML)
202. A study of prognostic factors in blast crisis of Philadelphia chromosome-positive chronic myelogenous leukaemia
203. Chronic myelogenous leukemia in blast crisis: Retrospective analysis of prognostic factors in 90 patients